NIMH Code: | B-917 |
Compound Name: | Buprenorphine hydrochloride |
Alternative Name: | (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol hydrochloride |
Abbreviation: | |
PubChemID: | 3033050 |
CAS: | 53152-21-9 |
Molecular Formula: | C29H42ClNO4 |
Biological Activity: | High affinity partial mu-opioid receptor agonist, used to treat opioid use disorder, acute pain, and chronic pain |
References: | Cowan, A.; Lewis, J. W.; Macfarlane, I. R. Br. J. Pharm. 1977, 60, 537-545. White, L.D.; Hodge, A., Vlok, R.; Hurtado, G.; Eastern, K., Melhuish, T.M., Br. J. Anaesth., 2018, 120, 668-678. |
Comments: | DEA schedule III controlled substance |
Last Updated 2021-02-17 11:23 AM |
Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.